Nanotherapeutics has held a Type C meeting with the FDA. The meeting provided an opportunity for the agency to review and provide feedback on Nanotherapeutics’ plans for its Advanced Development and Manufacturing (NANO-ADM) Center facility to be located in Copeland Park, Alachua, FL. The review and subsequent discussions with the FDA focused on the cGMP manufacturing space, which will provide Nanotherapeutics with capabilities to develop and produce bulk vaccines and biologics for the Departmen...